PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of chinesemjHomeCurrent issueInstructionsSubmit articleChinese Medical Journal
 
Chin Med J (Engl). 2017 April 5; 130(7): 776–781.
PMCID: PMC5381310

Epidemiological Features of Nontraumatic Spontaneous Subarachnoid Hemorrhage in China: A Nationwide Hospital-based Multicenter Study

Abstract

Background:

Nontraumatic spontaneous subarachnoid hemorrhage (SAH) is associated with a high mortality. This study was conducted to investigate the epidemiological features of nontraumatic spontaneous SAH in China.

Methods:

From January 2006 to December 2008, the clinical data of patients with nontraumatic SAH from 32 major neurosurgical centers of China were evaluated. Emergent digital subtraction angiography (DSA) was performed for the diagnosis of SAH sources in the acute stage of SAH (≤3 days). The results and complications of emergent DSA were analyzed. Repeated DSA or computed tomography angiography (CTA) was suggested 2 weeks later if initial angiographic result was negative.

Results:

A total of 2562 patients were enrolled, including 81.4% of aneurysmal SAH and 18.6% of nonaneurysmal SAH. The total complication rate of emergent DSA was 3.9% without any mortality. Among the patients with aneurysmal SAH, 321 cases (15.4%) had multiple aneurysms, and a total of 2435 aneurysms were detected. The aneurysms mostly originated from the anterior communicating artery (30.1%), posterior communicating artery (28.7%), and middle cerebral artery (15.9%). Among the nonaneurysmal SAH cases, 76.5% (n = 365) had negative initial DSA, including 62 cases with peri-mesencephalic nonaneurysmal SAH (PNSAH). Repeated DSA or CTA was performed in 252 patients with negative initial DSA, including 45 PNSAH cases. Among them, the repeated angiographic results remained negative in 45 PNSAH cases, but 28 (13.5%) intracranial aneurysms were detected in the remaining 207 cases. In addition, brain arteriovenous malformation (AVM, 7.5%), Moyamoya disease (7.3%), stenosis or sclerosis of the cerebral artery (2.7%), and dural arteriovenous fistula or carotid cavernous fistula (2.3%) were the major causes of nonaneurysmal SAH.

Conclusions:

DSA can be performed safely for pathological diagnosis in the acute stage of SAH. Ruptured intracranial aneurysms, AVM, and Moyamoya disease are the major causes of SAH detected by emergent DSA in China.

Keywords: Arteriovenous Malformation, Epidemiology, Intracranial Aneurysm, Moyamoya Disease, Subarachnoid Hemorrhage

Introduction

Nontraumatic spontaneous subarachnoid hemorrhage (SAH) is a neurologic emergency comprising 1–7% of all strokes, and the risks of morbidity and mortality associated with SAH are very high.[1] According to the WHO MONICA stroke study, the overall 28-day case fatality rate after SAH ictus was 41.7%.[2] As many as 46% of SAH survivors may have long-term cognitive impairment affecting functional status and quality of life due to symptomatic vasospasm.[3,4] Different sources of SAH may result in different outcomes, and the early diagnosis and management of SAH is now highly recommended by guidelines.[5] Therefore, we have to assess the safety and efficiency of emergent cerebral angiography for pathological diagnosis and understand the epidemiologic features of SAH in Chinese population. In this article, we report the results of a large multicenter epidemiology survey of nontraumatic SAH in China using cerebral angiography within the acute stages (≤3 days) of SAH.

Methods

This study was approved by Huashan Hospital Institutional Review Board, Fudan University, Shanghai, China. From January 2006 to December 2008, 32 major neurosurgical centers in China participated in this prospective observational survey. SAH was diagnosed by computed tomographic (CT) scan or lumbar puncture that was positive for xanthochromia in suspected cases. Patients aged <18 years or >80 years, or having a history of head trauma, were excluded from the study. Finally, a prospective database of patients with nontraumatic spontaneous SAH was established.

The pathological sources of SAH were evaluated by conventional catheter-based cerebral digital subtraction angiography (DSA) in the acute stages (≤3 days) of SAH. Standard angiographic views with/without supplementary oblique views were obtained through both internal or external carotid arteries and vertebral arteries. Rotational angiography and three-dimensional reconstruction were conducted for the clear identification of suspected hemorrhagic sources. If specific source of SAH was detected, it was called positive angiogram, otherwise it would be called negative angiogram. For those cases with negative initial angiogram in the acute stage of SAH, a repeat of DSA or CT angiography (CTA) was suggested 2 weeks later [Figure 1].

Figure 1
The flow diagram of the study. SAH: Subarachnoid hemorrhage; DSA: Digital subtraction angiography; PNSAH: Peri-mesencephalic nonaneurysmal SAH.

Basic clinical data including patients’ sex, age, smoking and drinking history, personal and family history, diabetes, hypertension, dyslipidemia, cause of bleeding, and drug use were collected. SAH was graded according to the modified Fisher scale that was based on hemorrhage pattern on admission CT.[6] Neurologic functional status on admission was evaluated using Hunt–Hess scale.[7,8] The results and complications of DSA were analyzed, and different angiographic results of SAH were recorded.

Statistical analysis was carried out using software SPSS 22.0 (IBM, USA). For comparisons of baseline characteristics between cohorts, Fisher's exact test and Chi-square test for categorical data and independent Student's t-test for continuous data were used. The statistical difference was considered as P < 0.05.

Results

A total of 2562 patients with nontraumatic spontaneous SAH were included in the survey. All SAH cases were revealed by CT or lumbar puncture, and hemorrhagic sources were identified by DSA in acute stages of SAH. The total complication rate of emergent DSA was 3.9% without any mortality, including 10 cases (0.4%) of rebleeding and 91 cases (3.5%) of cerebral vasospasm during DSA procedure.

Clinical characteristics of all SAH patients were summarized in Table 1. A total of 2085 (81.4%) cases with SAH were attributed to the rupture of intracranial aneurysms, while the other 477 (18.6%) cases were caused by other reasons. Patients with aneurysmal SAH were slightly older than those with nonaneurysmal SAH (51.8 ± 10.7 years vs. 49.5 ± 12.3, P < 0.001). Although more male patients with SAH were observed in this study, overall, aneurysmal SAH tended to occur more in female patients than nonaneurysmal SAH (48.7% vs. 42.3%, P = 0.012). There were no significant differences in smoking and drinking history, family history of cerebrovascular diseases, diabetes, or dyslipidemia between the aneurysmal SAH and nonaneurysmal SAH groups. However, more cases with hypertension were observed in the aneurysmal SAH group compared with the nonaneurysmal SAH group (30.8% vs. 17.8%, P < 0.001). About 260 (12.5%) patients in the aneurysmal SAH group had a history of previous rupture. The stimulation of hemorrhage was similar in both groups, except that more nonaneurysmal SAH might be associated with emotional excitement than aneurysmal SAH (13.0% vs. 9.0%, P = 0.007). The severity of SAH was worse in the aneurysmal SAH group because more cases with high modified Fisher scores were detected (P < 0.001). Therefore, state of consciousness and neurological function after SAH seemed to be better in the nonaneurysmal SAH group (P = 0.001) as evidenced by more cases having low Hunt–Hess scores.

Table 1
Clinical characteristics of subarachnoid hemorrhage patients in 32 centers

Among the aneurysmal SAH patients, 321 cases (15.4%) had multiple aneurysms, and a total of 2435 aneurysms were detected. The distribution of all aneurysms is listed in Table 2. Anterior communicating artery (AComA) aneurysms (30.1%, n = 734), posterior communicating artery (PComA) aneurysms (28.7%, n = 700), and middle cerebral artery (MCA) aneurysms (15.9%, n = 386) were the most common aneurysms detected in this study.

Table 2
Distribution of aneurysms among the aneurysmal subarachnoid hemorrhage patients

The distribution of nonaneurysmal SAH sources is summarized in Table 3. Nearly 76.5% (n = 365) had negative initial DSA with uncertain sources of bleeding. Among them, the pattern of peri-mesencephalic nonaneurysmal SAH (PNSAH) was detected in 62 cases (13.0% of all nonaneurysmal SAH). However, only 252 cases with negative initial angiogram, including 45 cases of PNSAH, accepted repeated DSA or CTA examination. The repeated angiographic result remained negative in 45 PNSAH cases, but 28 (13.5%) intracranial aneurysms were detected in the remaining 207 cases. On the contrary, in cases with positive DSA findings, brain arteriovenous malformation (AVM) (7.5%, n = 36), Moyamoya disease (7.3%, n = 35), stenosis or sclerosis of the cerebral artery (2.7%, n = 13), and dural arteriovenous fistula or carotid cavernous fistula (2.3%, n = 11) were the major specific causes of nonaneurysmal SAH.

Table 3
Etiology distribution of nonaneurysmal subarachnoid hemorrhage patients

Discussion

Previously, epidemiological studies revealed that SAH has a steady increase in incidence in the Chinese population.[9,10,11,12] The development of both diagnostic modalities and emergent rescuing capabilities is the most important contributor to this discrepancy. This study is based on nationwide data collected from 32 major neurosurgical centers and represents the largest hospital-based epidemiological analysis of SAH in China. We evaluated the effectiveness and safety of emergent DSA for the pathogenic diagnosis of SAH and depicted the etiological distribution of aneurysmal and nonaneurysmal SAH.

Undoubtedly, DSA is highly recommended as the primary method to elucidate the cause of SAH.[5] Due to the rapid development of neurosurgery in many hospitals in China, the emergent DSA for SAH patients was available almost at a nationwide level. The total complication rate of DSA in the acute stage of SAH in our cohort was limited to a satisfactory level (3.9%) without any death; however, it seems to be slightly higher compared with previous studies.[13,14] The reason may be that SAH itself is an independent risk factor of the DSA procedure and emergent DSA was performed just within 3 days after SAH ictus in our study.[13,14] Also unsurprisingly, vasospasm was the primary side effect of emergent DSA (90%), perhaps because the angiography procedure was performed in the highly agitated cerebral arteries during the acute stages of SAH or the vasospasm was just the pathological course of SAH itself instead of angiography.[15] In our opinion, due to the very low complication rate, we suggest that DSA can be performed safely for pathological diagnosis in the acute stage of SAH.

It is undisputed that intracranial aneurysm is the primary cause of SAH.[5,11] Our cohort is consistent with this feature. Older patients with hypertension appeared to be more susceptible to aneurysmal SAH. This finding may indicate that higher age is an important risk factor for cerebrovascular disease and that hypertension is involved in aneurysm formation and rupture. Most studies have demonstrated that female gender is a recognized risk factor for the occurrence of aneurysmal SAH.[16,17,18,19,20] Although the female-to-male ratio was approximately equal in our cohort, there was a gender difference between aneurysmal and nonaneurysmal SAH patients. The proportion of females was less in nonaneurysmal SAH patients. This demographic difference suggests that the underlying physiologic or anatomic processes of gender influence may be uniquely predisposed to either aneurysmal SAH or nonaneurysmal SAH.

For aneurysm location, anterior and posterior communicating arteries were the most common sites in aneurysmal SAH patients in this cohort. Middle cerebral artery bifurcation was another predominant site. These results are consistent with previous studies.[21,22,23,24] These three anatomical locations are susceptible to intracranial aneurysm due to the morphologic vulnerability and blood flow feature in the Willis circle, or because of arterial bifurcation. The finding that the proportion of posterior circulation aneurysms was lower has also been reported in previous studies, but still needs to be interpreted with caution due to the high mortality rate of those patients with ruptured posterior circulation aneurysms while on their way to hospital.[9,10,12]

Previous studies reported that the majority of patients with nonaneurysmal SAH were in good clinical condition on admission.[25,26,27] We replicated the same result with a lower Hunt–Hess score and modified Fisher's grade in nonaneurysmal SAH patients and most of the nonaneurysmal SAH were PNSAH or had uncertain sources (76.5%). These data confirmed a favorable outcome in nonaneurysmal SAH patients compared with aneurysmal SAH patients.[28,29]

The etiology of nonaneurysmal SAH varies, but usually there were no specific causes of bleeding in most of the nonaneurysmal SAH cases.[30] In our series, unknown sources of SAH account for approximately 76.5% of patients with nonaneurysmal SAH due to the negative initial angiogram, and PNSAH, which is a unique subset of SAH pattern, accounts for 13% of total nonaneurysmal SAH cases. According to the previous reports, the positive rate of repeated angiography for PNSAH was only 0–7%; however, 8–46% of non-PNSAH cases with negative initial angiogram might have positive findings during the second angiography.[30] Our results were consistent with those reports. None of the PNSAH were found to harbor intracranial aneurysms through repeated angiograms in our series. These findings strongly indicated that PNSAH was less likely to be associated with intracranial aneurysms.[30] The 13.5% positivity rate of repeated angiograms in non-PNSAH cases in our series also supports the necessity of further radiological examination for such kind of patients.

In the current study, only 23.5% of nonaneurysmal SAH cases had positive initial angiographic findings, and AVM and Moyamoya disease are the major sources of bleeding among them. As described in previous studies, rupture of superficial AVM could result in SAH, especially if there is an associated aneurysm in the nidus, but Moyamoya disease was rarely mentioned in reports beyond Asia. However, in previous decades, the number of confirmed Moyamoya disease has dramatically increased in Asia with a considerable group of patients presenting with SAH.[31,32] In our series, Moyamoya disease was the second most prevalent specific cause of nonaneurysmal SAH at a level similar to AVM, indicating the unique etiologic distribution features of SAH in China.

There are several limitations in our study. First, this is a descriptive cross-sectional study, lacking information on further treatment and outcomes. Second, the participating hospitals in this study were all large comprehensive hospitals. However, usually patients were firstly sent to either a district hospital or community hospital instead of large comprehensive hospitals. Therefore, the representativeness of the cohort in our study might be compromised.

In conclusion, we investigated the epidemiological features of nontraumatic spontaneous SAH in China and demonstrated that DSA can be performed safely for pathological diagnosis in the acute stage (≤3 days) of SAH. Ruptured intracranial aneurysm was the major cause of SAH in China. Most of the ruptured aneurysms detected by DSA are located in the AComA, PComA, and MCA. Nonaneurysmal SAH cases have better neurological status compared with aneurysmal cases. The majority of nonaneurysmal SAH have no specific causes, including PNSAH. AVM and Moyamoya disease may be secondary positive pathological causes of SAH in China except for intracranial aneurysms.

Financial support and sponsorship

This study was supported by grants from the National Key Technology R&D Program of the Ministry of Science and Technology of China (No. 2006BAI01A12 and No. 2011BAI08B06) and the Shanghai Hospital Developing Center Grant (No. SHDC12010118).

Conflicts of interest

There are no conflicts of interest.

Acknowledgement

The authors thank for the efforts of all investigators from: Huashan Hospital, Fudan University; Beijing Tian Tan Hospital, Capital Medical University; Changhai Hospital of Shanghai; Linfen People's Hospital; Nanjing General Hospital of Nanjing Military Command; Nanxishan Hospital of Guangxi Zhuang Autonomous Region; Peking University First Hospital; Peking University People's Hospital; Peking Union Medical College Hospital; Qilu Hospital of Shandong University; Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine; Shanghai Changzheng Hospital; Tangshan Gongren Hospital, Tangshan Clinical Medical College, Hebei Medical University; The Affiliated Hospital of Qingdao University; The Affiliated Hospital of Xuzhou Medical University; The First Affiliated Hospital of Chongqing Medical University; The First Affiliated Hospital of Fujian Medical University; The First Affiliated Hospital of Guangxi Medical University; The First Affiliated Hospital of Harbin Medical University; The First Affiliated Hospital of Nanchang University; The First Affiliated Hospital of Wenzhou Medical University; The First Hospital of China Medical University; The General Hospital of People's Liberation Army; The General Hospital of Shenyang Military Region; The Second Affiliated Hospital of Soochow University; The Second Affiliated Hospital of Zhejiang University School of Medicine; The Second Hospital of Shandong University; Tianjin Medical University General Hospital; Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology; West China Hospital, Sichuan University; Wuhan Union Hospital of Tongji Medical College, Huazhong University of Science and Technology; Xijin Hospital, The Fourth Military Medical University.

Footnotes

Edited by: Yi Cui

References

1. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: A review of population-based studies of incidence, prevalence, and case-fatality in the late 20thcentury. Lancet Neurol. 2003;2:43–53. doi: 10.1016/S1474-4422(03)00266-7. [PubMed]
2. Ingall T, Asplund K, Mähönen M, Bonita R. A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke. 2000;31:1054–61. doi: 10.1161/01.STR.31.5.1054. [PubMed]
3. Hackett ML, Anderson CS. Health outcomes 1 year after subarachnoid hemorrhage: An international population-based study. The Australian Cooperative Research on Subarachnoid Hemorrhage Study Group. Neurology. 2000;55:658–62. doi: 10.1212/WNL.55.5.658. [PubMed]
4. Mayer SA, Kreiter KT, Copeland D, Bernardini GL, Bates JE, Peery S, et al. Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage. Neurology. 2002;59:1750–8. doi: 10.1212/01.WNL.0000035748.91128.C2. [PubMed]
5. Connolly ES, Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:1711–37. doi: 10.1161/STR.0b013e3182587839. [PubMed]
6. Frontera JA, Claassen J, Schmidt JM, Wartenberg KE, Temes R, Connolly ES, Jr, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: The modified fisher scale. Neurosurgery. 2006;59:21–7. doi: 10.1227/01.NEU.0000218821.34014.1B. [PubMed]
7. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14–20. doi: 10.3171/jns.1968.28.1.0014. [PubMed]
8. Hunt WE, Kosnik EJ. Timing and perioperative care in intracranial aneurysm surgery. Clin Neurosurg. 1974;21:79–89. [PubMed]
9. Bian LH, Liu YF, Nichols LT, Wang CX, Wang YL, Liu GF, et al. Epidemiology of subarachnoid hemorrhage, patterns of management, and outcomes in China: A hospital-based multicenter prospective study. CNS Neurosci Ther. 2012;18:895–902. doi: 10.1111/cns.12001. [PubMed]
10. Jiang B, Wang WZ, Chen H, Hong Z, Yang QD, Wu SP, et al. Incidence and trends of stroke and its subtypes in China: Results from three large cities. Stroke. 2006;37:63–8. doi: 10.1161/01.STR.0000194955.34820.78. [PubMed]
11. Zhang J, Liu G, Arima H, Li Y, Cheng G, Shiue I, et al. Incidence and risks of subarachnoid hemorrhage in China. Stroke. 2013;44:2891–3. doi: 10.1161/STROKEAHA.113.002599. [PubMed]
12. Zhang LF, Yang J, Hong Z, Yuan GG, Zhou BF, Zhao LC, et al. Proportion of different subtypes of stroke in China. Stroke. 2003;34:2091–6. doi: 10.1161/01.STR.0000087149.42294.8C. [PubMed]
13. U-King-Im JM, Koo B, Trivedi RA, Higgins NJ, Tay KY, Cross JJ, et al. Current diagnostic approaches to subarachnoid haemorrhage. Eur Radiol. 2005;15:1135–47. doi: 10.1007/s00330-005-2665-5. [PubMed]
14. Kaufmann TJ, Huston J, 3rd, Mandrekar JN, Schleck CD, Thielen KR, Kallmes DF. Complications of diagnostic cerebral angiography: Evaluation of 19,826 consecutive patients. Radiology. 2007;243:812–9. doi: 10.1148/radiol.2433060536. [PubMed]
15. Cloft HJ, Joseph GJ, Dion JE. Risk of cerebral angiography in patients with subarachnoid hemorrhage, cerebral aneurysm, and arteriovenous malformation: A meta-analysis. Stroke. 1999;30:317–20. doi: 10.1161/01.STR.30.2.317. [PubMed]
16. Eden SV, Meurer WJ, Sánchez BN, Lisabeth LD, Smith MA, Brown DL, et al. Gender and ethnic differences in subarachnoid hemorrhage. Neurology. 2008;71:731–5. doi: 10.1212/01.wnl.0000319690.82357.44. [PMC free article] [PubMed]
17. Kongable GL, Lanzino G, Germanson TP, Truskowski LL, Alves WM, Torner JC, et al. Gender-related differences in aneurysmal subarachnoid hemorrhage. J Neurosurg. 1996;84:43–8. doi: 10.3171/jns.1996.84.1.0043. [PubMed]
18. Miranpuri AS, Aktüre E, Baggott CD, Miranpuri A, Uluç K, Günes VE, et al. Demographic, circadian, and climatic factors in non-aneurysmal versus aneursymal subarachnoid hemorrhage. Clin Neurol Neurosurg. 2013;115:298–303. doi: 10.1016/j.clineuro.2012.05.039. [PubMed]
19. Li MH, Chen SW, Li YD, Chen YC, Cheng YS, Hu DJ, et al. Prevalence of unruptured cerebral aneurysms in Chinese adults aged 35 to 75 years: A cross-sectional study. Ann Intern Med. 2013;159:514–21. doi: 10.7326/0003-4819-159-8-201310150-00004. [PubMed]
20. Gu YX, Chen XC, Song DL, Leng B, Zhao F. Risk factors for intracranial aneurysm in a Chinese ethnic population. Chin Med J. 2006;119:1359–64. [PubMed]
21. Spetzler RF, McDougall CG, Albuquerque FC, Zabramski JM, Hills NK, Partovi S, et al. The barrow ruptured aneurysm trial: 3-year results. J Neurosurg. 2013;119:146–57. doi: 10.3171/2013.3.JNS12683. [PubMed]
22. Spetzler RF, McDougall CG, Zabramski JM, Albuquerque FC, Hills NK, Russin JJ, et al. The barrow ruptured aneurysm trial: 6-year results. J Neurosurg. 2015;123:609–17. doi: 10.3171/2014.9.JNS141749. [PubMed]
23. Kerr R, Molyneux A. The barrow ruptured aneurysm trial and international subarachnoid aneurysm trial. J Neurosurg. 2013;118:478–80. doi: 10.3171/2012.2.JNS12190. [PubMed]
24. Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: A randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005;366:809–17. doi: 10.1016/S0140-6736(05)67214-5. [PubMed]
25. Gupta SK, Gupta R, Khosla VK, Mohindra S, Chhabra R, Khandelwal N, et al. Nonaneurysmal nonperimesencephalic subarachnoid hemorrhage: Is it a benign entity? Surg Neurol. 2009;71:566–71. doi: 10.1016/j.surneu.2008.04.021. [PubMed]
26. van Gijn J, van Dongen KJ, Vermeulen M, Hijdra A. Perimesencephalic hemorrhage: A nonaneurysmal and benign form of subarachnoid hemorrhage. Neurology. 1985;35:493–7. doi: 10.1212/WNL.35.4.493. [PubMed]
27. Ruigrok YM, Rinkel GJ, Buskens E, Velthuis BK, van Gijn J. Perimesencephalic hemorrhage and CT angiography: A decision analysis. Stroke. 2000;31:2976–83. doi: 10.1161/01.STR.31.12.2976. [PubMed]
28. Kang DH, Park J, Lee SH, Park SH, Kim YS, Hamm IS. Does non-perimesencephalic type non-aneurysmal subarachnoid hemorrhage have a benign prognosis? J Clin Neurosci. 2009;16:904–8. doi: 10.1016/j.jocn.2008.10.008. [PubMed]
29. Konczalla J, Platz J, Schuss P, Vatter H, Seifert V, Güresir E. Non-aneurysmal non-traumatic subarachnoid hemorrhage: Patient characteristics, clinical outcome and prognostic factors based on a single-center experience in 125 patients. BMC Neurol. 2014;14:140. doi: 10.1186/1471-2377-14-140. [PMC free article] [PubMed]
30. Little AS, Garrett M, Germain R, Farhataziz N, Albuquerque FC, McDougall CG, et al. Evaluation of patients with spontaneous subarachnoid hemorrhage and negative angiography. Neurosurgery. 2007;61:1139–50. doi: 10.1227/01.neu.0000306091.30517.e7. [PubMed]
31. Duan L, Bao XY, Yang WZ, Shi WC, Li DS, Zhang ZS, et al. Moyamoya disease in China: Its clinical features and outcomes. Stroke. 2012;43:56–60. doi: 10.1161/STROKEAHA.111.621300. [PubMed]
32. Jiang H, Ni W, Xu B, Lei Y, Tian Y, Xu F, et al. Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass. J Neurosurg. 2014;121:1048–55. doi: 10.3171/2014.7.JNS132434. [PubMed]

Articles from Chinese Medical Journal are provided here courtesy of Wolters Kluwer -- Medknow Publications